Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life

By sjmartinez • April 12, 2024

Greenstein YY, Hubel K, Froess J, Wisniewski SR, Venugopal V, Lai YH, Berger JS, Chang SY, Colovos C, Shah F, Kornblith LZ, Lawler PR, Gaddh M, Guerrero RM, Nkemdirim W, Lopes RD, Reynolds HR, Amigo JS, Wahid L, Zahra A, Goligher EC, Zarychanski R, Leifer E, Huang DT, Neal MD, Hochman JS, Cushman M, Gong MN. Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life. Chest. 2024 Apr;165(4):785-799. doi: 10.1016/j.chest.2023.11.019. Epub 2023 Nov 17. PMID: 37979717.

Tags: Anticoagulation, covid-19, Heparin, Publications, Pulmonary, Critical Care & Sleep Medicine, Quality of Life

Brief Report: Association of HIV and HCV With Adverse Coronary Artery Phenotypes in Women: Findings From a Cross-Sectional Study

Shitole SG, Chen E, Naveed M, Xue X, Sharma A, Hanna DB, Anastos K, Kaplan RC, Levsky JM, Tien PC, Radparvar AA, Bortnick AE, Budoff[...]

Urine-guided Hydration and Kidney Injury: Comment

Delaporte A, Maghen B, Grogan T, Legrand M, Joosten A. Urine-guided Hydration and Kidney Injury: Comment. Anesthesiology. 2026 Apr 9. doi: 10.1097/ALN.0000000000006003. Epub ahead of[...]

Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia

Zhang V, Barrett TD, Nemeth E, Ganz T. Mechanisms of resistance to Tmprss6 antisense oligonucleotides in a mouse model of β-thalassemia. Blood. 2026 Apr 9:blood.2026033274.[...]